Emyria Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Emyria.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth47.8%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Will Emyria (ASX:EMD) Spend Its Cash Wisely?

Feb 02
Will Emyria (ASX:EMD) Spend Its Cash Wisely?

We're Hopeful That Emyria (ASX:EMD) Will Use Its Cash Wisely

May 20
We're Hopeful That Emyria (ASX:EMD) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Emyria's (ASX:EMD) Cash Burn Situation

Oct 20
Here's Why We're Not Too Worried About Emyria's (ASX:EMD) Cash Burn Situation

We Think Emyria (ASX:EMD) Needs To Drive Business Growth Carefully

Jun 11
We Think Emyria (ASX:EMD) Needs To Drive Business Growth Carefully

Will Emyria (ASX:EMD) Spend Its Cash Wisely?

Feb 25
Will Emyria (ASX:EMD) Spend Its Cash Wisely?

Need To Know: Emyria Limited (ASX:EMD) Insiders Have Been Buying Shares

Nov 17
Need To Know: Emyria Limited (ASX:EMD) Insiders Have Been Buying Shares

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Emyria has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

ASX:EMD - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20242-11-6-4N/A
3/31/20242-12-6-5N/A
12/31/20232-12-7-5N/A
9/30/20232-9-7-4N/A
6/30/20232-5-7-4N/A
3/31/20232-6-8-5N/A
12/31/20222-8-9-6N/A
9/30/20222-7-8-6N/A
6/30/20222-7-7-5N/A
3/31/20222-7N/AN/AN/A
12/31/20212-6-6-4N/A
9/30/20212-6-5-4N/A
6/30/20212-5-5-4N/A
3/31/20212-5N/AN/AN/A
12/31/20202-5-5-4N/A
9/30/20201-5-5-4N/A
6/30/20201-5-5-4N/A
3/31/20201-5-4-4N/A
12/31/20191-4-3-3N/A
9/30/20190-3-3-3N/A
6/30/20190-3-3-3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if EMD's forecast earnings growth is above the savings rate (2.6%).

Earnings vs Market: Insufficient data to determine if EMD's earnings are forecast to grow faster than the Australian market

High Growth Earnings: Insufficient data to determine if EMD's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if EMD's revenue is forecast to grow faster than the Australian market.

High Growth Revenue: Insufficient data to determine if EMD's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if EMD's Return on Equity is forecast to be high in 3 years time


Discover growth companies